Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 63851-63900 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06119659
Safety and Efficacy Clinical Study of Severe Hemophilia B Treatment With KL001
EARLY_PHASE1Not yet recruiting
9 participants
Started: Nov 20, 2023 · Completed: Jul 10, 2025
1 condition1 sponsor0 locations
NCT06100874
A Single-arm Phase II Trial of SAcituzumab Govitecan and Trastuzumab for HER2+ Metastatic Breast Cancer After Trastuzumab dEruxtEcaN (SATEEN)
PHASE2Recruiting
40 participants
Started: Nov 20, 2023 · Completed: Nov 30, 2027
3 conditions2 sponsors4 locations
NCT06090045
Airway Involvement In Inflammatory Bowel Disease
N/ANot yet recruiting
70 participants
Started: Nov 20, 2023 · Completed: Dec 25, 2024
1 condition1 sponsor0 locations
NCT05884840
New Cardiovascular Risk Screening Strategy.
NARecruiting
54,000 participants
Started: Nov 20, 2023 · Completed: Jun 30, 2026
5 conditions5 sponsors1 location
NCT06116487
MRI as Alternative to CBCT for the Assessment of Furcation Involvement in Molars
N/ANot yet recruiting
140 participants
Started: Nov 20, 2023 · Completed: Dec 20, 2024
3 conditions1 sponsor1 location
NCT05350254
Implementation of the MAINTAIN Instrument for Patients With Dysfunctional Spinal Pain
NARecruiting
220 participants
Started: Nov 20, 2023 · Completed: Jul 31, 2025
3 conditions4 sponsors1 location
NCT06160739
Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations
N/ARecruiting
10 participants
Started: Nov 20, 2023 · Completed: Sep 1, 2024
3 conditions1 sponsor1 location
NCT06146803
"the Level of Resilience Influencing Self-care in Heart Failure Patients"
N/ARecruiting
300 participants
Started: Nov 20, 2023 · Completed: Nov 20, 2024
1 condition1 sponsor1 location
NCT06166719
Prediction of Complications After Major Gastrointestinal Surgery With Machine Learning and Point of Care Ultrasound
N/ARecruiting
200 participants
Started: Nov 20, 2023 · Completed: Jan 20, 2026
2 conditions2 sponsors1 location
NCT06131385
Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China(IVTIS)
N/ARecruiting
3,000 participants
Started: Nov 20, 2023 · Completed: May 1, 2046
1 condition1 sponsor1 location
NCT06140511
DREAMER - IsolateD REM Sleep Without Atonia as a Risk Factor for REM Sleep Behavior disordER
N/ANot yet recruiting
600 participants
Started: Nov 20, 2023 · Completed: May 19, 2025
1 condition4 sponsors0 locations
NCT06131840
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
PHASE1Recruiting
494 participants
Started: Nov 20, 2023 · Completed: Sep 12, 2030
6 conditions2 sponsors28 locations
NCT04808427
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
NARecruiting
21 participants
Started: Nov 20, 2023 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT05796869
The Effect of Laughter Therapy On The Food Craving
NARecruiting
90 participants
Started: Nov 20, 2023 · Completed: Jan 30, 2024
3 conditions1 sponsor1 location
NCT06143397
Effect of TTNS and PNS on Neurogenic Overactive Bladder Symptoms in Female Patients With Multiple Sclerosis.
NARecruiting
42 participants
Started: Nov 20, 2023 · Completed: Oct 30, 2025
2 conditions2 sponsors1 location
NCT06029621
Robot-assisted vs VATS for Thymoma
NARecruiting
304 participants
Started: Nov 20, 2023 · Completed: Sep 19, 2030
1 condition1 sponsor2 locations
NCT06428513
Health Coaching Telemedicine Program for Lung Transplant Candidates With End-stage Lung Disease.
NARecruiting
56 participants
Started: Nov 19, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT06625528
The Present Study Was Performed to Evaluate the Efficacy of Lyophilized-PRF in Treatment of Periodontal Intra-bony Defects
EARLY_PHASE1Active, not recruiting
36 participants
Started: Nov 19, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06199765
Risk Perception of Needlestick Injury
NAActive, not recruiting
90 participants
Started: Nov 19, 2023 · Completed: Jan 11, 2024
1 condition1 sponsor1 location
NCT05939700
Mavacamten Pregnancy Surveillance Program
N/ARecruiting
20 participants
Started: Nov 19, 2023 · Completed: Apr 30, 2027
3 conditions1 sponsor1 location
NCT06185543
A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.
PHASE2Recruiting
20 participants
Started: Nov 19, 2023 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06120985
Rural Appalachia Pilot Water Treatment Trial
NAActive, not recruiting
200 participants
Started: Nov 19, 2023 · Completed: Dec 31, 2025
3 conditions4 sponsors2 locations
NCT06056063
Project Looking-Glass Evaluation
NAActive, not recruiting
27 participants
Started: Nov 19, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06294301
A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants
PHASE1Recruiting
78 participants
Started: Nov 19, 2023 · Completed: Oct 30, 2024
1 condition1 sponsor1 location
NCT06918080
Hepatoprotective Measures for Children at High Risk of NAFLD
PHASE4Active, not recruiting
200 participants
Started: Nov 19, 2023 · Completed: Jul 31, 2025
3 conditions1 sponsor2 locations
NCT06400446
The Effect of Kangaroo Care After Cardiac Surgery
NARecruiting
60 participants
Started: Nov 19, 2023 · Completed: May 20, 2024
1 condition1 sponsor1 location
NCT05839470
Cadonilimab Plus FOLFOXIRI and Bevacizumab as First Line Therapy for Metastatic MSS Colorectal Cancer
PHASE2Recruiting
20 participants
Started: Nov 19, 2023 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT06412692
Motivational Interviewing in Adolescents With Epilepsy
NAEnrolling by invitation
72 participants
Started: Nov 18, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06135584
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NANot yet recruiting
1,000 participants
Started: Nov 18, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor0 locations
NCT04332068
Ivermectin Safety in Small Children
PHASE2Recruiting
399 participants
Started: Nov 18, 2023 · Completed: Dec 31, 2024
1 condition5 sponsors3 locations
NCT05797792
CHemical OptImization of Cerebral Embolectomy 2 (CHOICE 2).
PHASE3Active, not recruiting
440 participants
Started: Nov 18, 2023 · Completed: Nov 14, 2025
2 conditions1 sponsor14 locations
NCT07009340
Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery
N/AActive, not recruiting
200 participants
Started: Nov 18, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT05629754
10-year Follow-up After Tibial Tubercle Transposition
N/AEnrolling by invitation
32 participants
Started: Nov 18, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT05491226
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
PHASE2Active, not recruiting
35 participants
Started: Nov 17, 2023 · Completed: Dec 1, 2026
2 conditions3 sponsors1 location
NCT06130787
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy
NARecruiting
321 participants
Started: Nov 17, 2023 · Completed: Nov 17, 2028
1 condition1 sponsor17 locations
NCT05976165
A Study of Breath Testing for Small Intestinal Bacterial Overgrowth
NARecruiting
50 participants
Started: Nov 17, 2023 · Completed: Jan 31, 2026
3 conditions1 sponsor1 location
NCT05874921
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
N/ARecruiting
400 participants
Started: Nov 17, 2023 · Completed: Jan 31, 2028
8 conditions1 sponsor22 locations
NCT06057571
Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor
PHASE2Active, not recruiting
50 participants
Started: Nov 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor29 locations
NCT06341894
Efficacy and Safety of Dalpiciclib With Endocrine Therapy as Adjuvant Treatment in HR+/ HER2- Early Breast Cancer
PHASE2Recruiting
1,163 participants
Started: Nov 17, 2023 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT05789589
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
PHASE1/PHASE2Recruiting
46 participants
Started: Nov 17, 2023 · Completed: Aug 31, 2027
5 conditions3 sponsors1 location
NCT06177860
Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
N/ARecruiting
400 participants
Started: Nov 17, 2023 · Completed: Nov 30, 2024
4 conditions1 sponsor1 location
NCT06153810
Efficacy of AesyBite Active in Reducing Sleep Bruxism Activity
NARecruiting
26 participants
Started: Nov 17, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05624879
Accelerated Resolution Therapy for Early Maladaptive Grief
NARecruiting
440 participants
Started: Nov 17, 2023 · Completed: Mar 14, 2028
1 condition2 sponsors4 locations
NCT06022016
Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene.
NARecruiting
910 participants
Started: Nov 17, 2023 · Completed: Jan 31, 2030
1 condition1 sponsor5 locations
NCT06115746
A Randomized Clinical Trial of a Novel Drug Education and Diversion Program (iDECIDE) for Middle and High School Students
NARecruiting
300 participants
Started: Nov 17, 2023 · Completed: Jul 31, 2026
3 conditions2 sponsors1 location
NCT06230796
Effects of Functional Electrical Stimulation Assisted Cycling in Patients With Hemiparesis After Stroke
NARecruiting
30 participants
Started: Nov 17, 2023 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05903807
[68Ga]Ga-FAPI-46 PET/CT in Ovarian Cancer
PHASE2Recruiting
50 participants
Started: Nov 17, 2023 · Completed: Jan 1, 2035
1 condition1 sponsor1 location
NCT06345898
Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)
EARLY_PHASE1Recruiting
12 participants
Started: Nov 17, 2023 · Completed: Nov 30, 2033
1 condition1 sponsor1 location
NCT06353152
Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells for Gastric/Gastroesophageal Junction Adenocarcinoma
PHASE1Recruiting
12 participants
Started: Nov 17, 2023 · Completed: Nov 16, 2025
2 conditions2 sponsors1 location
NCT05817825
Pilot Testing a Novel Remotely Delivered Intensive Outpatient Program for Individuals With OUD
NARecruiting
20 participants
Started: Nov 17, 2023 · Completed: Dec 31, 2024
2 conditions3 sponsors1 location